Skip to main content
Literatur
1.
Zurück zum Zitat Cui N, Cai H, Li Z, et al. Tigecycline-induced coagulopathy: a literature review. Int J Clin Pharm. 2019;41:1408–13.CrossRef Cui N, Cai H, Li Z, et al. Tigecycline-induced coagulopathy: a literature review. Int J Clin Pharm. 2019;41:1408–13.CrossRef
2.
Zurück zum Zitat Zhang Q, Zhou S, Zhou J. Tigecycline treatment causes a decrease in fibrinogen levels. Antimicrob Agents Chemother. 2015;59:1650–5.CrossRef Zhang Q, Zhou S, Zhou J. Tigecycline treatment causes a decrease in fibrinogen levels. Antimicrob Agents Chemother. 2015;59:1650–5.CrossRef
3.
Zurück zum Zitat Hakeam HA, Al Duhailib Z, Salahuddin N, Amin T. Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study. J Chemother. 2018;30:224–32.CrossRef Hakeam HA, Al Duhailib Z, Salahuddin N, Amin T. Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study. J Chemother. 2018;30:224–32.CrossRef
4.
Zurück zum Zitat Neerman-Arbez M, Casini A. Clinical consequences and molecular bases of low fibrinogen levels. Int J Mol Sci. 2018;19:192.CrossRef Neerman-Arbez M, Casini A. Clinical consequences and molecular bases of low fibrinogen levels. Int J Mol Sci. 2018;19:192.CrossRef
5.
Zurück zum Zitat Balfousias T, Apostolopoulos AP, Angelis S, et al. Spontaneous knee hemarthrosis due to hypofibrinogenemia following tigecycline treatment for periprosthetic joint infection. Cureus. 2019;11:e5883.PubMedPubMedCentral Balfousias T, Apostolopoulos AP, Angelis S, et al. Spontaneous knee hemarthrosis due to hypofibrinogenemia following tigecycline treatment for periprosthetic joint infection. Cureus. 2019;11:e5883.PubMedPubMedCentral
6.
Zurück zum Zitat Sabanis N, Paschou E, Gavriilaki E, et al. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder. Infect Dis (Lond). 2015;47:743–6.CrossRef Sabanis N, Paschou E, Gavriilaki E, et al. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder. Infect Dis (Lond). 2015;47:743–6.CrossRef
7.
Zurück zum Zitat Ahmed S, Oropello JM. Critical care issues in oncological surgery patients. Crit Care Clin. 2010;26:93–106.CrossRef Ahmed S, Oropello JM. Critical care issues in oncological surgery patients. Crit Care Clin. 2010;26:93–106.CrossRef
Metadaten
Titel
Tigecycline-induced coagulopathy: a literature review
verfasst von
Hakeam A. Hakeam
Zainab Al Duhailib
Publikationsdatum
27.03.2020
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2020
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-00974-w

Weitere Artikel der Ausgabe 3/2020

International Journal of Clinical Pharmacy 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.